Our latest Visit press room
Featured Innovator: Nathan Collins
Nathan Collins, CSO SRI Biosciences discusses current and future plans for leveraging AI to help advance modern chemistry and SRI’s related work in the biosciences industry.
Announcements May 26, 2020
Developing the next generation of PCR diagnostics for point-of-contact screening
SRI International investigator awarded NSF grant for development of a point of contact diagnostic for infectious diseases.
Event June 3
SRI CISO, Surbhi Tugnawat to join Women in Cybersecurity Panel
Join key female leaders in cybersecurity on June 3rd.
In the news May 22, 2020
SRI International and Exscientia hope to accelerate the development of new cancer therapies
June 2020 – SRI AI and COVID-19
SRI’s tech enables spin-off Decoded Health, and global collaboration with synthetic-chemistry system, SynFini™.
A history of firsts
From the computer mouse to robotic surgery, cancer treatments, and more, SRI’s 70+ years of innovation have created new industries, billions of dollars in market value, and lasting benefits to society.
Areas of expertise
Advanced imaging systems
Biomedical R&D services
Cyber & formal methods
Education & learning
Innovation strategy & design
Ocean & space
Robotics, sensors & devices
Speech & natural language
Ventures & licensing
Video test & measurement
SRI is truly a bridge between academia and industry with fast-paced, milestone driven research. If you can imagine, they give you the tools to create. I’ve had the opportunity to work with and get trained by some of the coolest minds here and my mentors have always been supportive in my career development as an early scientist.
Postdoctoral Fellow, Biosciences